Brain-gut interactions in inflammatory bowel disease

Area of Science:

• Neurogastroenterology
• Psychoneuroimmunology
• Inflammatory Bowel Disease Pathogenesis

Background:

• The brain-gut axis, involving neural, endocrine, and immune systems, is implicated in inflammatory bowel disease (IBD).
• Key components include the central nervous system, autonomic nervous system, hypothalamic-pituitary-adrenal axis, and intestinal responses.
• Psychological factors like stress and mood disorders are increasingly recognized as influencing IBD.

Purpose of the Study:

• To explore the role of the brain-gut axis in IBD pathogenesis.
• To identify potential therapeutic targets within the neuro-immune pathways.
• To highlight the importance of psychological interventions in IBD management.

Main Methods:

• Review of animal models and clinical evidence on brain-gut interactions in IBD.
• Analysis of the cholinergic anti-inflammatory pathway and vagus nerve function.
• Consideration of psychophysiological vulnerability and coping strategies in IBD patients.

Main Results:

• The cholinergic anti-inflammatory pathway, particularly via the vagus nerve's anti-tumor necrosis factor effect, presents a potential therapeutic target.
• Psychological distress and maladaptive coping strategies are prevalent and may impact IBD disease course.
• Markers like cortisol, heart rate variability, and brain imaging could elucidate brain-gut interactions.

Conclusions:

• Modulation of the brain-gut axis offers promising therapeutic strategies for IBD.
• Pharmacological, nutritional, or neurostimulation approaches targeting the cholinergic pathway warrant further investigation.
• Integrating psychological interventions alongside conventional treatments may improve IBD outcomes.